ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676497 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676497; 2) Community: the network communities that were significantly associated with the response to NSC 676497; 3) Molecule: the relationships between components within communities and NSC 676497; 4) MDR: the compounds that were significantly associated with the NSC 676497.

NSC Compound Enrichment Correlation
NSC 6926 Null 0.0366216145653013 -0.29528176
NSC 694619 Null 0.0366216145653013 -0.36791812
NSC 697535 Null 0.0366216145653013 0.034215655
NSC 718781 Erlotinib hydrochloride 0.0366216145653013 0.29912119
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0366216145653013 -0.37406006
NSC 726217 Combretastatin A4-analogue 0.0366216145653013 -0.2733031
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0366216145653013 -0.24552191
NSC 734287 6-(3-Aminopropyl)-5,6-dihydro-7,8,9-trimethoxy-3-nitro-5,11- dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0366216145653013 -0.24497588
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0366216145653013 -0.46872188
NSC 743532 Null 0.0366216145653013 0.060742554
Total:49  Current:37    [First] [Prev] [Next] [Last]